Erratum: Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells (Blood (2017) 129:10 (1343-1356) DOI: 10.1182/blood-2016-04-713206);Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells

Blood

Volumn 129, Issue 10, 2017, Pages 1343-1356

  Marini, Olivia ^a   Costa, Sara ^a   Bevilacqua, Dalila ^a   Calzetti, Federica ^a   Tamassia, Nicola ^a   Spina, Cecilia ^a   De Sabata, Donata ^a   Tinazzi, Elisa ^b   Lunardi, Claudio ^b   Scupoli, Maria T ^a   Cavallini, Chiara ^a   Zoratti, Elisa ^a   Tinazzi, Ilaria ^c   Marchetta, Antonio ^c   Vassanelli, Aurora ^d   Cantini, Maurizio ^d   Gandini, Giorgio ^d   Ruzzenente, Andrea ^a   Guglielmi, Alfredo ^a   Missale, Francesco ^a   Vermi, William ^e   Tecchio, Cristina ^a   Cassatella, Marco A ^a   Scapini, Patrizia ^a   more..

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD16 ANTIGEN; CD18 ANTIGEN; CD66B ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GAMMA INTERFERON; LENOGRASTIM; MEMBRANE METALLOENDOPEPTIDASE; PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; CELL SEPARATION; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEUTROPHIL;

BIOMARKERS; CELL SEPARATION; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOCYTE ACTIVATION; NEPRILYSIN; NEUTROPHILS; T-LYMPHOCYTES;

EID: 85015156159     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-05-783423     Document Type: Erratum

References (65)

1. Mócsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med. 2013;210(7):1283-1299.
2. Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol. 2014;15(7):602-611.
3. Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Annu Rev Pathol. 2014;9:181-218.
4. Scapini P, Cassatella MA. Social networking of human neutrophils within the immune system. Blood. 2014;124(5):710-719.
5. Kruger P, Saffarzadeh M, Weber AN, et al. Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog. 2015; 11(3):e1004651.
6. Leliefeld PH, Koenderman L, Pillay J. How neutrophils shape adaptive immune responses. Front Immunol. 2015;6:471.
7. Carmona-Rivera C, Kaplan MJ. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol. 2013;35(4):455-463.
8. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother. 2012; 61(8):1155-1167.
9. Pillay J, Tak T, Kamp VM, Koenderman L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol Life Sci. 2013;70(20):3813-3827.
10. Scapini P, Marini O, Tecchio C, Cassatella MA. Human neutrophils in the saga of cellular heterogeneity: insights and open questions. Immunol Rev. 2016;273(1):48-60.
11. Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci. 2014;1319:47-65.
12. Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013; 13(10):739-752.
13. Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28(2): 187-196.
14. Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog. 2014;10(3):e1003993.
15. Cloke T, Munder M, Bergin P, et al. Phenotypic alteration of neutrophils in the blood of HIV seropositive patients. PLoS One. 2013;8(9): e72034.
16. Darcy CJ, Minigo G, Piera KA, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care. 2014;18(4):R163.
17. Rieber N, Wecker I, Neri D, et al. Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD. Bone Marrow Transplant. 2014;49(4):545-552.
18. Köstlin N, Kugel H, Spring B, et al. Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses. Eur J Immunol. 2014;44(9): 2582-2591.
19. Luyckx A, Schouppe E, Rutgeerts O, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol. 2012; 143(1):83-87.
20. Vasconcelos ZF, Santos BM, Costa ES, et al. T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. Cytotherapy. 2003;5(4):336-345.
21. Choi J, Suh B, Ahn YO, et al. CD151/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol. 2012;33(1):121-129.
22. Tsuda Y, Fukui H, Asai A, et al. An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. J Clin Biochem Nutr. 2012;51(3): 204-212.
23. Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012;122(1):327-336.
24. de Kleijn S, Langereis JD, Leentjens J, et al. IFN-g-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLoS One. 2013;8(8):e72249.
25. Hao S, Andersen M, Yu H. Detection of immune suppressive neutrophils in peripheral blood samples of cancer patients. Am J Blood Res. 2013;3(3):239-245.
26. Elghetany MT. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis. 2002;28(2):260-274.
27. Cossman J, Neckers LM, Leonard WJ, Greene WC. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J Exp Med. 1983;157(3):1064-1069.
28. McCormack RT, Nelson RD, LeBien TW. Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils. J Immunol. 1986;137(3):1075-1082.
29. Scapini P, Calzetti F, Cassatella MA. On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J Immunol Methods. 1999;232(1-2):121-129.
30. Zimmermann M, Aguilera FB, Castellucci M, et al. Chromatin remodelling and autocrine TNFa are required for optimal interleukin-6 expression in activated human neutrophils. Nat Commun. 2015; 6:6061.
31. Gorczyca W, Sun ZY, Cronin W, Li X, Mau S, Tugulea S. Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol. 2011;103:221-266.
32. Pelletier M, Maggi L, Micheletti A, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood. 2010;115(2):335-343.
33. Hock BD, Taylor KG, Cross NB, Kettle AJ, Hampton MB, McKenzie JL. Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology. 2012;137(3):249-258.
34. Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB. Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma. 2010;68(4):843-852.
35. Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009; 69(4):1553-1560.
36. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 2001;61(12):4756-4760.
37. Marini O, Spina C, Mimiola E, et al. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget. 2016;7(19):27676-27688.
38. Brandau S, Moses K, Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin Cancer Biol. 2013;23(3):171-182.
39. Pedersen CC, Borup R, Fischer-Nielsen A, et al. Changes in gene expression during g-csf-induced emergency granulopoiesis in humans. J Immunol. 2016;197(5):1989-1999.
40. Manz MG, Boettcher S. Emergency granulopoiesis. Nat Rev Immunol. 2014;14(5): 302-314.
41. Jacobsen LC, Theilgaard-Mönch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood. 2007;109(7):3084-3087.
42. Cloke T, Munder M, Taylor G, Müller I, Kropf P. Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS One. 2012;7(11): e48939.
43. Ssemaganda A, Kindinger L, Bergin P, et al. Characterization of neutrophil subsets in healthy human pregnancies. PLoS One. 2014;9(2): e85696.
44. Hübl W, Andert S, Thum G, Ortner S, Bayer PM. Value of neutrophil CD16 expression for detection of left shift and acute-phase response. Am J Clin Pathol. 1997;107(2):187-196.
45. Fagny C, Marchant A, De Prez E, Goldman M, Deschodt-Lanckman M. Lipopolysaccharide induces upregulation of neutral endopeptidase 24.11 on human neutrophils: involvement of the CD14 receptor. Clin Sci (Lond). 1995;89(1):83-89.
46. Erdös EG, Wagner B, Harbury CB, Painter RG, Skidgel RA, Fa XG. Down-regulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils. J Biol Chem. 1989;264(24):14519-14523.
47. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood. 1991;78(7):1834-1841.
48. Giallongo C, Parrinello N, Tibullo D, et al. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients. PLoS One. 2014;9(7):e101848.
49. Casbon AJ, Reynaud D, Park C, et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc Natl Acad Sci USA. 2015;112(6):E566-E575.
50. Waight JD, Hu Q, Miller A, Liu S, Abrams SI. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One. 2011;6(11):e27690.
51. Trellakis S, Bruderek K, Hütte J, et al. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer. Innate Immun. 2013;19(3):328-336.
52. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother. 2011;60(10): 1419-1430.
53. Raychaudhuri B, Rayman P, Ireland J, et al. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol. 2011;13(6):591-599.
54. Bendall LJ, Bradstock KF. G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014;25(4):355-367.
55. Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine. 2008;42(3):277-288.
56. Orr Y, Taylor JM, Bannon PG, Geczy C, Kritharides L. Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release. Br J Haematol. 2005;131(4):508-519.
57. Guérin E, Orabona M, Raquil MA, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration∗. Crit Care Med. 2014;42(9):2007-2018.
58. Mare TA, Treacher DF, Shankar-Hari M, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care. 2015;19(1):57.
59. Bae MH, Park SH, Park CJ, et al. Flow cytometric measurement of respiratory burst activity and surface expression of neutrophils for septic patient prognosis. Cytometry B Clin Cytom. 2016; 90(4):368-375.
60. Demaret J, Venet F, Friggeri A, et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol. 2015;98(6):1081-1090.
61. Singhal S, Bhojnagarwala PS, O'Brien S, et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 2016;30(1):120-135.
62. Lv M, Zhao XS, Hu Y, et al. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2015;90(1):E9-E16.
63. 1 cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood. 1997; 89(5):1629-1634.
64. Vendramin A, Gimondi S, Bermema A, et al. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells. Biol Blood Marrow Transplant. 2014;20(12):2049-2055.
65. Maguer-Satta V, Besançon R, Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells. 2011;29(3): 389-396.